Simplex Trading
TBPH icon

Simplex Trading’s Theravance Biopharma TBPH Stock Holding History

Simplex Trading’s Portfolio TBPH Stock Details TBPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.4K Sell
2,800
-27,300
-91% -$483K ﹤0.01% 5980
2025
Q4 		$563K Buy
30,100
+500
+2% +$8.29K ﹤0.01% 3184
2025
Q3 		$432K Buy
+29,600
New +$374K ﹤0.01% 4005
2024
Q2 		– Sell
-1,100
Closed -$9K – 9803
2024
Q1 		$9K Sell
1,100
-84,800
-99% -$786K ﹤0.01% 7705
2023
Q4 		$965K Buy
85,900
+43,400
+102% +$437K ﹤0.01% 3029
2023
Q3 		$366K Buy
42,500
+28,400
+201% +$274K ﹤0.01% 3724
2023
Q2 		$145K Sell
14,100
-59,900
-81% -$661K ﹤0.01% 4657
2023
Q1 		$802K Sell
74,000
-44,700
-38% -$473K ﹤0.01% 2796
2022
Q4 		$1.33M Buy
118,700
+27,300
+30% +$287K ﹤0.01% 2201
2022
Q3 		$926K Buy
91,400
+87,600
+2,305% +$821K ﹤0.01% 2736
2022
Q2 		$34K Sell
3,800
-4,100
-52% -$37.8K ﹤0.01% 6995
2022
Q1 		$75K Sell
7,900
-14,200
-64% -$139K ﹤0.01% 6557
2021
Q4 		$244K Buy
22,100
+19,800
+861% +$173K ﹤0.01% 4883
2021
Q3 		$33K Hold
2,300
– – ﹤0.01% 8009
2021
Q2 		$33K Buy
2,300
+2,288
+19,067% +$43K ﹤0.01% 8146
2021
Q1 		$24K Buy
+12
New +$228 ﹤0.01% 7317
2020
Q4 		– Sell
-30
Closed -$44K – 9071
2020
Q3 		$44K Buy
30
+13
+76% +$244 ﹤0.01% 5733
2020
Q2 		$35K Sell
17
-34
-67% -$873 ﹤0.01% 5801
2020
Q1 		$117K Sell
51
-2
-4% -$50 ﹤0.01% 4204
2019
Q4 		$137K Buy
+53
New +$1.03K ﹤0.01% 4161
2019
Q3 		– Sell
-5
Closed -$8K – 7877
2019
Q2 		$8K Buy
+5
New +$101 ﹤0.01% 6242
2019
Q1 		– Sell
-1
Closed -$2K – 7823
2018
Q4 		$2K Sell
1
-1
-50% -$27 ﹤0.01% 6614
2018
Q3 		$6K Sell
2
-1
-33% -$27 ﹤0.01% 6698
2018
Q2 		$6K Buy
+3
New +$71 ﹤0.01% 6638
2018
Q1 		– Sell
-16
Closed -$2K – 6849
2017
Q4 		$2K Sell
16
-1
-6% -$30 ﹤0.01% 5260
2017
Q3 		$11K Buy
17
+4
+31% +$131 ﹤0.01% 3703
2017
Q2 		$8K Hold
13
– – ﹤0.01% 4201
2017
Q1 		$7K Sell
13
-14
-52% -$447 ﹤0.01% 4324
2016
Q4 		$7K Buy
+27
New +$838 ﹤0.01% 4086

Other funds holding TBPH

MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's TBPH Position: Q3 2025 in Review

Simplex Trading sold out of Theravance Biopharma (TBPH) in Q3 2025, closing a stake of 697 shares — an estimated $8.81K sold.

Simplex Trading first reported a position in TBPH in Q1 2016 and held it in 25 quarters. The position peaked at $487K in Q3 2022. 162 funds tracked by Wall St. Rank hold TBPH as of Q3 2025.

  • Simplex Trading reported no remaining Theravance Biopharma position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 697 Theravance Biopharma shares in Q3 2025, an estimated $8.81K.
  • Simplex Trading first reported a position in Theravance Biopharma in Q1 2016 and held it in 25 quarters.
  • Simplex Trading's Theravance Biopharma position peaked at $487K in Q3 2022.
  • 162 funds tracked by Wall St. Rank held Theravance Biopharma as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.